SIRT3 and metabolic dysfunction-associated steatohepatitis: Thus, in ovx females, Sirt3 may protect from NASH by upregulation of ho-1, while in the absence of Sirt3 the expression of ho-1 is abolished, making these mice more susceptible to the development of NASH caused by HFD.